Virus News and Research

Latest Virus News and Research

New Hampshire begins statewide West Nile virus detection activities

The New Hampshire Department of Health and Human Services' Division of Public Health Services (DPHS) has begun statewide West Nile virus detection activities in partnership with other state agencies

9 Jun 2004

British people unaware that cervical cancer is linked to human papillomavirus (HPV)

Most people in the UK do not know that cervical cancer is linked to a common sexually transmitted virus, according to a Cancer Research UK study published on (Monday).

7 Jun 2004

Neuroscientists have overcome a major obstacle in gene therapy research

Northwestern University neuroscientists have overcome a major obstacle in gene therapy research. They've devised a method that will safely deliver and regulate expression of therapeutic genes introduced into the central nervous system to treat Parkinson's disease and other neurodegenerative diseases.

5 Jun 2004

Latest version of the Approved List of Biological Agents published

The Advisory Committee on Dangerous Pathogens (ACDP) today published the latest version of the Approved List of Biological Agents.('The Approved List').

3 Jun 2004

Ethiopia needs external help fighting the HIV/AIDS pandemic

Ethiopia has taken crucial steps to fight the HIV/AIDS pandemic, but the east African country urgently needs external assistance if its efforts are to meet with success, a senior United Nations official said today.

2 Jun 2004

Studies suggest white tea help prevent staphylococcus and streptococcus infections

New studies conducted at Pace University, have indicated that White Tea Extract (WTE) may have prophylactic applications in retarding growth of bacteria that cause Staphylococcus infections, Streptococcus infections, pneumonia and dental caries.

2 Jun 2004

West Nile virus found in Illinois crows

Dead crows found in Stephenson and Winnebago counties have tested positive for West Nile virus, Dr. Eric E. Whitaker, state public health director, today reported.

2 Jun 2004

Double-punch approach to vaccine design more effective

A study revealing new information about how viral proteins move between cells and alert the immune system suggests that a double-punch approach to vaccine design would make them more effective.

1 Jun 2004

West Nile set to explode in summer 2004

Experts predict the continued spread of West Nile virus this summer, with the potential for serious outbreaks in numerous states, including California.

1 Jun 2004

Gay men casual about HIV

One in three HIV positive gay men don't know they are infected with the virus, suggests a large community study in Sexually Transmitted Infections.

1 Jun 2004

The new European Health Insurance Card explained

The European Health Insurance Card has come into circulation today (1st June 2004). The aim of the card is to simplify procedures for accessing the healthcare system in another Member State.

1 Jun 2004

Engineered virus could be ideal for targeting cancers with lethal gene therapy

Scientists from Cancer Research UK have taken advantage of the selfish behaviour of cancer cells to target them with a genetically engineered virus.

1 Jun 2004

Higher rate of cancer in meat industry

A study of over 6600 meat industry workers around New Zealand has found a significantly high rate of cancers, particularly lung cancer, which may be caused by exposure to cancer causing agents carried by animals.

31 May 2004

Women exposed in adulthood to cytomegalovirus may be at greater risk of breast cancer

A study just published in the prestigious British Journal of Cancer by researchers at the University of Otago's Christchurch School of Medicine and Health Sciences and Dunedin School of Medicine, and the University of Melbourne, has found evidence of a link between a common virus and breast cancer in women under the age of 40 years.

31 May 2004

Bird flu vaccine

The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has awarded two contracts to support the production and clinical testing of an investigational vaccine based on a strain of avian influenza, H5N1, which might have the potential to cause pandemic influenza.

27 May 2004

Blueprint for rational design of vaccines that induce desired T-cell responses

Investigators from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, have conducted studies in mice to gain a new picture of how the immune system’s “killer” T cells are prompted to destroy infected cells. Their insights provide a blueprint for rational design of vaccines that induce desired T-cell responses.

27 May 2004

The Health Protection Agency starts surveillance programme for human cases of West Nile virus infection

The Health Protection Agency is starting its annual enhanced surveillance programme for possible human cases of West Nile virus infection. The scheme, which has been used for the last three years, operates during the summer, when there is West Nile virus activity in other countries.

27 May 2004

Update on West Nile virus in Texas

In 2004, West Nile has been detected in five horses in Brazoria, Fort Bend, La Salle, Leon and Montgomery counties and in seven birds in Harris, Lubbock and Montgomery counties. No human cases have been recorded in 2004 in Texas.

27 May 2004

New study challenges current thinking about varied response to hepatitis C treatment in different racial groups

Results of a new study published in the current issue of the New England Journal of Medicine show that in patients who have chronic hepatitis C, genotype 1 -- the most common form of the disease and difficult to treat successfully -- non-Hispanic whites achieved one of the highest response rates reported to date, but response rates in African Americans were significantly lower.

27 May 2004

Human Genome Sciences has begun dosing patients with chronic hep C drug

Human Genome Sciences, Inc. announced today that it has begun dosing patients in a Phase 2 clinical trial of Albuferon™ (albumin-interferon alpha) in patients with chronic hepatitis C who are naïve to interferon-alpha treatments.

27 May 2004